|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 9/16 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| C07D 498/22 | (2006.01) |
| (11) | Number of the document | 2593463 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11807418.6 |
| Date of filing the European patent application | 2011-07-12 | |
| (97) | Date of publication of the European application | 2013-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation | 2020-08-25 |
| (86) | Number | PCT/US2011/043769 |
| Date | 2011-07-12 |
| (87) | Number | WO 2012/009388 |
| Date | 2012-01-19 |
| (30) | Number | Date | Country code |
| 419056 P | 2010-12-02 | US | |
| 363609 P | 2010-07-12 | US |
| (72) |
SELBO, Jon, US
TENG, Jing, US
KABIR, Mohammed, A., US
GOLDEN, Pam, US
|
| (73) |
Salix Pharmaceuticals, Inc.,
400 Somerset Corporate Boulevard, Bridgewater, NJ 08807,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Rifaksimino kompozicijos ir jų panaudojimas |
| FORMULATIONS OF RIFAXIMIN AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-05-22 | 15 | 289.00 EUR |
| 2026-07-12 |